This finding is supported by a previous study that showed high immunohistochemical expression of ST3GalI and ST6GalI in cutaneous epithelial lesions including keratoacanthoma, AK, BCC, and SCC. This evidence concerns the gene ST3GAL1 and skin basal cell carcinoma.